Dichotic listening before and after fluoxetine treatment for major depression: relations of laterality to therapeutic response.
Despite the wide variance in therapeutic response to antidepressants, there are few clinical or biological predictors of treatment outcome. Studies have suggested the possible value of dichotic listening measures of perceptual asymmetry (PA) as predictors of treatment response. This study examined the relation between outcome of fluoxetine treatment and performance on verbal and nonverbal dichotic tests. As part of a multisite study, 86 outpatients with major depression were tested on dichotic fused-words and complex-tones tests both before and during treatment. Fluoxetine responders differed from nonresponders in having greater right-ear (left-hemisphere) advantage for dichotic words and less left-ear (right-hemisphere) advantage for complex tones. There was no change in PA during fluoxetine treatment, which indicates that PA differences between treatment responders and nonresponders are stable (trait) characteristics. An aggregate, characteristic PA measure was the best predictor of responder status in a logistic regression analysis. Findings from two clinical centers support the hypothesis that a characteristic tendency for relatively greater left-than right-hemispheric activation during dichotic listening is associated with better outcome of fluoxetine treatment.
Bruder
G E
GE
Department of Biopsychology, New York State Psychiatric Institute, NY 10032, USA.
Otto
M W
MW
McGrath
P J
PJ
Stewart
J W
JW
Fava
M
M
Rosenbaum
J F
JF
Quitkin
F M
FM
D000161:Acoustic Stimulation; D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D001307:Auditory Perception / Q000187:drug effects / Q000502:physiology; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology*; D004007:Dichotic Listening Tests; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use*; D007839:Functional Laterality / Q000502:physiology*; D006801:Humans; D008297:Male; D011569:Psychiatric Status Rating Scales; D012044:Regression Analysis
D018687:Antidepressive Agents, Second-Generation; D005473:Fluoxetine